276 related articles for article (PubMed ID: 30216219)
1. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
Sun B; Liu H; Wang S; Xiang J; Liu X
J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
[TBL] [Abstract][Full Text] [Related]
5. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.
Sohn TA; Lillemoe KD; Cameron JL; Huang JJ; Pitt HA; Yeo CJ
J Am Coll Surg; 1999 Jun; 188(6):658-66; discussion 666-9. PubMed ID: 10359359
[TBL] [Abstract][Full Text] [Related]
6. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
7. Underutilization of Surgery in Periampullary Cancer Treatment.
Michalski CW; Liu B; Heckler M; Roth S; Sun H; Heger U; Büchler MW; Hackert T
J Gastrointest Surg; 2019 May; 23(5):959-965. PubMed ID: 30088190
[TBL] [Abstract][Full Text] [Related]
8. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
9. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
10. The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors.
Brooks AD; Mallis MJ; Brennan MF; Conlon KC
J Gastrointest Surg; 2002; 6(2):139-45; discussion 145-6. PubMed ID: 11992798
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
[TBL] [Abstract][Full Text] [Related]
12. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
13. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
14. Postoperative complications influence prognosis and recurrence patterns in periampullary cancer.
Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim YK
World J Surg; 2013 Sep; 37(9):2234-41. PubMed ID: 23722466
[TBL] [Abstract][Full Text] [Related]
15. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
16. Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.
Bhatti AB; Yusuf MA; Kazmi SA; Syed AA
World J Surg; 2014 Oct; 38(10):2506-13. PubMed ID: 24858190
[TBL] [Abstract][Full Text] [Related]
17. Reoperative surgery for periampullary adenocarcinoma.
McGuire GE; Pitt HA; Lillemoe KD; Niederhuber JE; Yeo CJ; Cameron JL
Arch Surg; 1991 Oct; 126(10):1205-10; discussion 1210-2. PubMed ID: 1681794
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
19. A study of forty-nine consecutive Whipple resections for periampullary adenocarcinoma.
Sung JP; Stewart RD; O'Hara VS; Westhpal KF; Wilkinson JE; Hill J
Am J Surg; 1997 Jul; 174(1):6-10. PubMed ID: 9240943
[TBL] [Abstract][Full Text] [Related]
20. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
